Structure Therapeutics officer to sell $140K stock

An officer of Structure Therapeutics Inc. filed a Rule 144 notice to sell 4,008 GPCR common shares valued at $140,280 through a broker.

Available on EDGAR 09/21/2026 - 04:36 PM EDT Accepted by SEC EDGAR 09/21/2026 - 04:35 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Structure Therapeutics Inc. (GPCR) received a notice that officer Blas Coll Crespo has filed to sell up to 4,008 shares of the company’s common stock under Rule 144. The shares, valued at an aggregate $140,280.00 as of September 21, 2026 on Nasdaq, were acquired from Restricted Stock Units granted by the issuer on September 18, 2026 and are to be sold through Morgan Stanley Smith Barney LLC.

Key Figures

Shares to be sold: 4,008 shares Aggregate market value: $140,280.00 Security identifier: 213929572 +2 more

5 metrics

Shares to be sold 4,008 shares Common stock covered by the Rule 144 notice for Blas Coll Crespo

Aggregate market value $140,280.00 Value of 4,008 shares of Structure Therapeutics Inc. common stock listed for sale

Security identifier 213929572 Identifier listed for the common stock in the Form 144 securities information section

Acquisition date of shares September 18, 2026 Date shares were acquired from the issuer as Restricted Stock Units

Proposed sale date reference September 21, 2026 Date tied to the Nasdaq market value in the Form 144

Key Terms

Rule 144, Restricted Stock Units, Executive Financial Services

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 09/18/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for GPCR disclose about planned share sales?

The filing states that officer Blas Coll Crespo plans to sell up to 4,008 shares of Structure Therapeutics Inc. common stock under Rule 144, with an aggregate value of $140,280.00 as of September 21, 2026, through Morgan Stanley Smith Barney LLC on Nasdaq.

How many Structure Therapeutics Inc. (GPCR) shares are covered by this Rule 144 notice?

The notice covers up to 4,008 shares of Structure Therapeutics Inc. common stock. These shares are to be sold for the account of officer Blas Coll Crespo through Morgan Stanley Smith Barney LLC under Rule 144.

What is the stated value of the GPCR shares in this Form 144 filing?

The Form 144 lists an aggregate market value of $140,280.00 for the 4,008 shares of Structure Therapeutics Inc. common stock to be sold on Nasdaq for the account of Blas Coll Crespo.

How were the GPCR shares in this Form 144 acquired?

The 4,008 shares of Structure Therapeutics Inc. common stock covered by the notice were acquired on September 18, 2026 from the issuer as Restricted Stock Units, according to the Form 144 disclosure.

Which broker is handling the planned GPCR share sale disclosed in Form 144?

The planned sale of 4,008 shares of Structure Therapeutics Inc. common stock for Blas Coll Crespo will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, per the Form 144 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002037144
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Structure Therapeutics Inc.
SEC File Number	001-41608
Address of Issuer	601 Gateway Blvd., Suite 900 South San Francisco CALIFORNIA 94080
Phone	6504571978
Name of Person for Whose Account the Securities are To Be Sold	BLAS COLL CRESPO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4008	140280.00	213929572	09/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/18/2026	Restricted Stock Units	Issuer			4008	09/18/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Blas Coll Crespo
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)